Skip to main content
Premium Trial:

Request an Annual Quote

LifeCodexx, LifeCell Partner to Offer PrenaTest in India

NEW YORK (GenomeWeb) – LifeCodexx announced today that it has signed an agreement to sell its PrenaTest noninvasive prenatal screening test in India through preventative healthcare provider LifeCell.

According to LifeCodexx, LifeCell will offer the test under its BabyShield brand. Additional terms of the deal were not disclosed.

"We are very pleased to have partnered with LifeCell since they have a longstanding expertise in the field of preventive healthcare services for mother and child in the Indian market," LifeCodexx CEO Michael Lutz said in a statement.

Earlier this year, LifeCodexx partnered with Sengenics to sell PrenaTest in Southeast Asia. And last year, LifeCodexx forged alliances with other companies covering the UK and Ireland, Germany, and Switzerland.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.